These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4455619)

  • 1. Immunity in cholera.
    Ghosh AK
    Indian J Pathol Bacteriol; 1974 Apr; 17(2):118-25. PubMed ID: 4455619
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraduodenal inoculation of adult rabbits for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains.
    García Imia L; Oliva Hernández R; Cedré Marrero B; Valmaseda Pérez T; García Sánchez H; Talavera Coronel A; Pérez Quiñoy JL; Sierra González G
    Lab Anim Sci; 1998 Oct; 48(5):538-41. PubMed ID: 10090073
    [No Abstract]   [Full Text] [Related]  

  • 3. [Determination of Vibrio antibody titers during anti-cholera vaccination].
    Dirimci OT; Cinar V
    Turk Hij Tecr Biyol Derg (1961); 1973; 33(2-3):118-28. PubMed ID: 4807572
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholera antibody response in immunized persons in a cholera free area. II. Vibriocidal antibodies.
    Chirescu N; Năcescu N; Ciufecu C
    Arch Roum Pathol Exp Microbiol; 1974 Jun; 33(2):149-53. PubMed ID: 4412422
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of cross-protection against diarrhea due to Vibrio cholerae O1 after oral immunization of rabbits with V. cholerae O139 Bengal.
    Albert MJ; Alam K; Rahman AS; Huda S; Sack RB
    J Infect Dis; 1994 Mar; 169(3):709-10. PubMed ID: 8158063
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunity in experimental cholera: effect of parenteral immunization with vaccines and toxoid.
    Sinha VB; Bhaskaran K
    Bull World Health Organ; 1973; 49(6):605-13. PubMed ID: 4548387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
    Cryz SJ; Fürer E; Germanier R
    Dev Biol Stand; 1983; 53():67-72. PubMed ID: 6873478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral immunization with a probiotic cholera vaccine induces broad protective immunity against Vibrio cholerae colonization and disease in mice.
    Sit B; Zhang T; Fakoya B; Akter A; Biswas R; Ryan ET; Waldor MK
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007417. PubMed ID: 31150386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation in tablets of a cholera whole cells inactivated vaccine candidate.
    Talavera A; Año G; Pino Y; Castaño J; Uribarri E; Riverón L; Gil S; Fernández S; Cedré B; Valmaseda T; Pérez JL; Infante JF; García L; Sierra G
    Vaccine; 2006 Apr; 24(16):3381-7. PubMed ID: 16460846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of antibody responses and protective immunity in cholera vaccinated subjects.
    Chaicumpa W; Pacharaprakiti C; Plueksawan W; Atthasishtha N
    Southeast Asian J Trop Med Public Health; 1980 Mar; 11(1):58-66. PubMed ID: 7403955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated recombinant strains of Vibrio cholerae for oral immunization.
    Srivastava BS; Sinha VB; Srivastava R
    Bull World Health Organ; 1979; 57(4):649-54. PubMed ID: 316742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental heat-inactivated cholera vaccine for intradermal use.
    Ciufecu C; Năcescu N; Chirescu N; Israil A; Stefănescu C
    Arch Roum Pathol Exp Microbiol; 1983; 42(1):59-64. PubMed ID: 6336507
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylactic significance of the nonlipopolysaccharide antigens of Vibrio cholerae.
    Attridge SR; Rowley D
    J Infect Dis; 1983 Nov; 148(5):931-9. PubMed ID: 6195273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selection of attenuated Vibrio cholerae strains to obtain oral attenuated candidate vaccines against cholera].
    María García H; Año G; Cedré B; Valmaseda T; Maestre JL; Díaz M; Mirabal M; Talavera A; García L
    Rev Cubana Med Trop; 2005; 57(2):92-104. PubMed ID: 17966578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.
    Cash RA; Music SI; Libonati JP; Craig JP; Pierce NF; Hornick RB
    J Infect Dis; 1974 Oct; 130(4):325-33. PubMed ID: 4443613
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunisation against cholera with a Ty21a-cholera hybrid.
    La Brooy JT; Forrest B; Bartholomeusz C
    Ann Sclavo Collana Monogr; 1986; 3(1-2):143-7. PubMed ID: 3426872
    [No Abstract]   [Full Text] [Related]  

  • 18. An oral cholera vaccine for travelers (Vaxchora).
    Med Lett Drugs Ther; 2016 Aug; 58(1502):113-4. PubMed ID: 27552209
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serologic response in man to cholera vaccine].
    Di Tommaso I
    Ann Sclavo; 1973; 15(4):445-52. PubMed ID: 4788453
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhancement of protection against experimental cholera in rabbits by prior immunization of BCG along with Vibrio cholerae.
    Ghose AC; Majumdar AS
    Indian J Med Res; 1979 Mar; 69():383-9. PubMed ID: 447377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.